Siemens Healthcare has announced that the U.S. Food and Drug Administration (FDA) has cleared the new Prime edition of its Acuson SC2000 premium cardiovascular imaging system — a system that offers live full-volume color Doppler imaging of heart valve anatomy and blood flow using a new true volume transesophageal echo (TEE) probe.


In a new study recently published in the Annals of Internal Medicine, researchers at NYU Langone Medical Center concluded that overuse of cardiac stress testing with imaging has led to rising healthcare costs and unnecessary radiation exposure to patients.

 

October 20, 2014 — Boston Scientific Corp. has initiated the PLATINUM Diversity trial to evaluate the clinical performance of the Promus Premier Everolimus-Eluting Platinum Chromium Coronary Stent System in underserved patient populations, including women and people of color. The Promus Premier stent system is the company's latest durable polymer drug-eluting stent (DES) and is approved by the U.S. Food and Drug Administration (FDA) to treat coronary artery disease. Wayne Batchelor, M.D., FACC, FSCAI, and co-principal investigator, enrolled the first patient in the PLATINUM Diversity trial at Tallahassee Memorial Hospital, in Tallahassee, Fla.

October 20, 2014 — Sony Electronics’ Medical Systems Division is highlighting four new medical printers at RSNA 2014: models UP-D898MD, UP-X898MD, UP-991AD and UP-971AD. Each new model is Food and Drug Administration (FDA) Class II, 510(k) cleared. The new printers are designed for increased efficiency and performance in a range of radiology applications, including ultrasound, portable C-Arm and cardiac cath labs.

Heart disease and stroke are the leading causes of death and disability among people with Type 2 diabetes. At least 65 percent of people with diabetes die from some form of heart disease or stroke, according to the American Heart Association.

Boston Scientific Corp. has received CE mark approval for the Accolade pacemaker family. 

Subscribe Now